暨南大学学报(自然科学与医学版)
暨南大學學報(自然科學與醫學版)
기남대학학보(자연과학여의학판)
JOURNAL OF JINAN UNIVERSITY(NATURAL SCIENCE & MEDICINE EDITION)
2015年
3期
228-232
,共5页
王明军%张金荣%徐婉梅%黎伟%张影华%张元元%何建静%廖蕴华
王明軍%張金榮%徐婉梅%黎偉%張影華%張元元%何建靜%廖蘊華
왕명군%장금영%서완매%려위%장영화%장원원%하건정%료온화
激素抵抗%微小病变%肾病综合征%多因素分析
激素牴抗%微小病變%腎病綜閤徵%多因素分析
격소저항%미소병변%신병종합정%다인소분석
steroid-resistant%minimal change disease%nephrotic syndrome%multivariate analy-sis
目的:探讨微小病变性肾病综合征激素抵抗的相关危险因素.方法:回顾性调查68例经肾组织活检确诊为微小病变性肾小球肾炎患者临床资料,实验室检查结果及随访情况,将患者分为激素抵抗组(30例)及非抵抗组(38例),采用 SPSS17.0软件,进行单因素分析,对有意义的单因素采用二分类 Logistic 回归进行多因素分析,绘制受试者工作特性曲线(ROC)评价检验指标在预测微小病变性肾病综合征激素抵抗时的敏感度,特异度和最佳临界值.结果:单因素分析显示合并感染、尿镜下红细胞水平、总胆固醇、24h 尿蛋白定量、高尿酸,血清白蛋白及补体 C4下降是激素抵抗型微小病变性肾病综合征的相关因素(P≤0.05),有统计学差异.多因素分析显示感染、尿镜下红细胞水平、24 h 尿蛋白定量是激素抵抗型微小病变性肾病综合征的独立危险因素,OR(95%IC)分别为4.265(1.033~17.609,P =0.045)、2.468(1.124~5.420,P =0.024)、1.001(1.000~1.002,P =0.039).ROC 曲线分析显示当尿镜下红细胞≥3.5/HP,24 h 尿蛋白定量超过5.57 g/d,总胆固醇高于9.49 mmol/L 是判断激素抵抗型微小病变性肾病综合征的最佳诊断临界值.结论:(1)感染、血尿、24 h 尿蛋白定量是激素抵抗型微小病变性肾病综合征的独立危险因素.(2)当出现血尿,24 h 尿蛋白定量≥5.57 g/d,总胆固醇≥9.49 mmol/L 时应警惕激素抵抗型微小病变性肾病综合征的发生.
目的:探討微小病變性腎病綜閤徵激素牴抗的相關危險因素.方法:迴顧性調查68例經腎組織活檢確診為微小病變性腎小毬腎炎患者臨床資料,實驗室檢查結果及隨訪情況,將患者分為激素牴抗組(30例)及非牴抗組(38例),採用 SPSS17.0軟件,進行單因素分析,對有意義的單因素採用二分類 Logistic 迴歸進行多因素分析,繪製受試者工作特性麯線(ROC)評價檢驗指標在預測微小病變性腎病綜閤徵激素牴抗時的敏感度,特異度和最佳臨界值.結果:單因素分析顯示閤併感染、尿鏡下紅細胞水平、總膽固醇、24h 尿蛋白定量、高尿痠,血清白蛋白及補體 C4下降是激素牴抗型微小病變性腎病綜閤徵的相關因素(P≤0.05),有統計學差異.多因素分析顯示感染、尿鏡下紅細胞水平、24 h 尿蛋白定量是激素牴抗型微小病變性腎病綜閤徵的獨立危險因素,OR(95%IC)分彆為4.265(1.033~17.609,P =0.045)、2.468(1.124~5.420,P =0.024)、1.001(1.000~1.002,P =0.039).ROC 麯線分析顯示噹尿鏡下紅細胞≥3.5/HP,24 h 尿蛋白定量超過5.57 g/d,總膽固醇高于9.49 mmol/L 是判斷激素牴抗型微小病變性腎病綜閤徵的最佳診斷臨界值.結論:(1)感染、血尿、24 h 尿蛋白定量是激素牴抗型微小病變性腎病綜閤徵的獨立危險因素.(2)噹齣現血尿,24 h 尿蛋白定量≥5.57 g/d,總膽固醇≥9.49 mmol/L 時應警惕激素牴抗型微小病變性腎病綜閤徵的髮生.
목적:탐토미소병변성신병종합정격소저항적상관위험인소.방법:회고성조사68례경신조직활검학진위미소병변성신소구신염환자림상자료,실험실검사결과급수방정황,장환자분위격소저항조(30례)급비저항조(38례),채용 SPSS17.0연건,진행단인소분석,대유의의적단인소채용이분류 Logistic 회귀진행다인소분석,회제수시자공작특성곡선(ROC)평개검험지표재예측미소병변성신병종합정격소저항시적민감도,특이도화최가림계치.결과:단인소분석현시합병감염、뇨경하홍세포수평、총담고순、24h 뇨단백정량、고뇨산,혈청백단백급보체 C4하강시격소저항형미소병변성신병종합정적상관인소(P≤0.05),유통계학차이.다인소분석현시감염、뇨경하홍세포수평、24 h 뇨단백정량시격소저항형미소병변성신병종합정적독립위험인소,OR(95%IC)분별위4.265(1.033~17.609,P =0.045)、2.468(1.124~5.420,P =0.024)、1.001(1.000~1.002,P =0.039).ROC 곡선분석현시당뇨경하홍세포≥3.5/HP,24 h 뇨단백정량초과5.57 g/d,총담고순고우9.49 mmol/L 시판단격소저항형미소병변성신병종합정적최가진단림계치.결론:(1)감염、혈뇨、24 h 뇨단백정량시격소저항형미소병변성신병종합정적독립위험인소.(2)당출현혈뇨,24 h 뇨단백정량≥5.57 g/d,총담고순≥9.49 mmol/L 시응경척격소저항형미소병변성신병종합정적발생.
Aim:To evaluate risk factors of steroid-resistant minimal change nephrotic syndrome. Methods:retrospectively analysed 68 patients who were confirmed as minimal-change nephritic syndrome by renal biopsies,and divided as group steroid-resistant group(n =30)and non steroid-resistant group(n=38).A univariate analysis was performed firstly.Then the significant ones were performed a multivari-ate analysis by using binary Logistic regression model.Lastly,the sensitivity,the specificity,and the best threshold value of the indexes,which as indicating the steroid-resistant minimal change disease,was testi-fied by drawing a receiver operating characteristic curve(ROC).Results:(1)combined infection(P =0.014),red blood cell count(P =0.005 ),total cholesterol (P =0.015 ),24 h urinary protein (P = <br> 0.000),serum albumin(P =0.011),high urine uric acid(P =0.045),C4 decrease(P =0.028)were all the risk factors of steroid-resistant minimal change disease(P <0.05).(2)And infection(OR 4.265, 95%IC =1.033 ~17.609 P =0.045),red blood cell count(OR 2.468,95%IC =1.124 ~5.420 P =0.024),24 h urinary protein(OR =1.001,95%IC =1.000 ~1.002,P =0.039),were independent risk factors of steroid-resistant minimal change disease.(4)Red blood cell count in urine >3.5 /HP,24 h u-rinary protein >5.57 g/d total cholesterol >9.49 mmol /L were the best threshold value indicating ster-oid-resistant minimal change disease.Conclusion:(1)infection,hematuria,24 h urinary protein quanti-tative is independent risk factors of Steroid-resistant minimal change nephrotic syndrome.(2)when Oc-cur hematuria,24 h urinary proteind≥5.57 g/d,total cholesterol≥9.49 mmol /L,,Should be alert to the occurrence of Steroid-resistant minimal change nephrotic syndrome.